摘要
背景:细胞异质性存在于不同的组织之间,即使是同一类型的细胞。细胞异质性导致细胞大小、功能和生物活性的差异,对癌细胞来说,它导致不同的药物反应和耐药性。同时,微流体是一个很有前途的工具,以揭示单细胞研究的细胞异质性。 方法:通过近十年的文献研究,我们总结和介绍了微流控技术在单细胞分离和操作方面的应用,包括声学操作、光学操作、单细胞捕获和模式等技术。以及单细胞组学,包括单细胞基因组学、单细胞转录组学、单细胞蛋白质组学、单细胞代谢组学和药物开发。 结果:微流体是一种灵活、精确的工具,易于与不同的功能集成。首先,根据细胞的生物学或物理特性,它可以作为分离稀有但重要细胞的重要工具。其次,微流体可以提供单细胞组学的可能性。第三,微流体可以用于药物开发,特别是药物传递和药物组合。与此同时,液滴微流体已逐渐成为用其他试剂封装单细胞进行DNA、RNA或蛋白质分析的最有力工具。 结论:微流体技术是一种强大的平台技术,能够完成罕见的细胞分离、高效的单细胞组学分析,并为药物开发和给药提供平台。
关键词: 微流体,单细胞操作,单细胞组学,药物开发,蛋白质分析,细胞分离。
Current Medicinal Chemistry
Title:Application of Microfluidics in Single-cell Manipulation, Omics and Drug Development
Volume: 28 Issue: 40
关键词: 微流体,单细胞操作,单细胞组学,药物开发,蛋白质分析,细胞分离。
摘要:
Background: Cell heterogeneity exists among different tissues, even in the same type of cells. Cell heterogeneity leads to a difference in cell size, functions, biological activity, and for cancer cells it causes different drug responses and resistance. Meanwhile, microfluidics is a promising tool for single-cell research to reveal cell heterogeneity.
Methods: Through literature research conducted over the past ten years on microfluidics, we summarize and introduce the application of microfluidics in single-cell separation and manipulation, featuring techniques, such as acoustic manipulation, optical manipulation, single-cell trapping, and patterning, as well as single-cell omics including singlecell genomics, single-cell transcriptomics, single-cell proteome, single-cell metabolome, and drug development.
Results: Microfluidics is a flexible, precise tool, and it is easy to integrate with different functions. Firstly, it can be used as an important tool to separate rare but important cells according to the cell`s biological or physical properties. Secondly, microfluidics can provide the possibility of single-cell omics. Thirdly, microfluidics can be used in drug development, specifically in drug delivery and drug combination. Meanwhile, droplet microfluidics has gradually become the most powerful tool to encapsulate single-cells with other reagents for DNA, RNA, or protein analysis.
Conclusion: Microfluidics is a robust platform technology that is able to accomplish rare cell separation, efficient single-cell omics analysis and provide a platform for drug development and drug delivery.
Export Options
About this article
Cite this article as:
Application of Microfluidics in Single-cell Manipulation, Omics and Drug Development, Current Medicinal Chemistry 2021; 28 (40) . https://dx.doi.org/10.2174/0929867328666210203205641
DOI https://dx.doi.org/10.2174/0929867328666210203205641 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Quinolinyl–1,3,4–Oxadiazoles: Synthesis, In Vitro Antibacterial, Antifungal and Antituberculosis Studies
Medicinal Chemistry Structural Requirements for Efficient Phosphorylation of Nucleotide Analogs by Human Thymidylate Kinase
Mini-Reviews in Medicinal Chemistry Detecting Gene-Gene Interactions Associated with Multiple Complex Traits with U-Statistics
Current Genomics A Review of the Ethnopharmacology, Phytochemistry and Pharmacology of Plants of the Maytenus Genus
Current Pharmaceutical Design Evaluation of Synthetic Cell-Penetrating Peptides, Pro-Rich Peptide and Octaargine Derivatives, as Adenovirus Vector Carrier
Protein & Peptide Letters A Review of Light Sources and Enhanced Targeting for Photodynamic Therapy
Current Medicinal Chemistry Cell Surface Nucleolin as a Target for Anti-Cancer Therapies
Recent Patents on Anti-Cancer Drug Discovery The Effects of Sevoflurane or Remifentanil on the Stress Response to Surgical Stimulus
Current Pharmaceutical Design 4-Oxa-1-azabicyclo[3.2.0]heptan-7-one Derivatives as Anti-Tumor Agents
Current Medicinal Chemistry - Anti-Cancer Agents Targeted Nanosystems to Prostate Cancer
Current Pharmaceutical Design Computational Analysis of Phosphoproteomics: Progresses and Perspectives
Current Protein & Peptide Science Hypoxic Radiosensitizers and Hypoxic Cytotoxins in Radiation Oncology
Current Medicinal Chemistry - Anti-Cancer Agents Hydroxytyrosol Expresses Antifungal Activity In Vitro
Current Drug Targets Searching for Therapeutics Against Botulinum Neurotoxins: A True Challenge for Drug Discovery
Current Topics in Medicinal Chemistry Preparation and Characterization of Highly Fluorescent TGA-CdTe Quantum Dot-Hyamine 1622 Additive Composite
Micro and Nanosystems Stabilisation of G-Quadruplex DNA by Small Molecules
Current Topics in Medicinal Chemistry Neonatal Brain Hemorrhage (NBH) of Prematurity: Translational Mechanisms of the Vascular-Neural Network
Current Medicinal Chemistry Emerging Role for Antioxidant Therapy in Protection Against Diabetic Cardiac Complications: Experimental and Clinical Evidence for Utilization of Classic and New Antioxidants
Current Cardiology Reviews Electronic Noses in Medical Diagnostics
Current Medicinal Chemistry Gold and Silver Nanoparticles in Bioassay, Cell Visualization and Therapy
Current Clinical Pharmacology